Epitenon-derived progenitor cells in tendon healing and adaptation
表腱衍生的祖细胞在肌腱愈合和适应中的作用
基本信息
- 批准号:10852086
- 负责人:
- 金额:$ 7.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdministrative SupplementAdrenal Cortex HormonesAffectAmericanAnti-Inflammatory AgentsAreaAwardBehavioralBiological MarkersBiological ProductsBiologyBiomechanicsCell Differentiation processCellsCellular biologyClinicClinicalDataData SetDependenceDepositionExhibitsFutureGenesGeneticGoalsHand StrengthHistologicHistologyImmuneInflammatoryInjuryInterventionKnock-outKnowledgeMeasurementMeasuresMediatingMethodsModelingMorphologyMusMusculoskeletal DiseasesNociceptorsNon-Steroidal Anti-Inflammatory AgentsOpioidOutcome MeasurePainPain ResearchPain managementParentsPathologyPatientsPersistent painPharmaceutical PreparationsPlayPopulationProcessPropertyProtease InhibitorPublic HealthQuality of lifeRheumatismRodentRoleSiteTendon InjuriesTendon structureTestingTimeTissuesdata reusedesignefficacy testingexperimental studyfunctional outcomesgait examinationhealingimprovedinnovationinsightknock-downmouse modelnegative affectnovelopioid usepain inhibitionpressurepreventprogenitorrecruitresponsesecondary analysissingle-cell RNA sequencingskin disorderstem cellstherapeutic targettreatment effect
项目摘要
Project Summary
Pain associated with tendon injuries is an difficult clinical problem that significantly affects the overall quality of
life of affected patients. Current treatments for tendon pain are anti-inflammatory drugs (non-steroidal anti-
inflammatory drugs (NSAIDS) and corticosteroids) or opioids; however, anti-inflammatory drugs can negatively
affect the tendon healing process and long-term opioid use can lead to dependency and contributes to the
national opioid public health crisis. Thus, the need for novel, more targeted mechanisms to alleviate pain in
tendon injuries is high. The parent award seeks to define the overall role that epitenon cells play in tendon healing
using a novel driver (GLASTCreERT) to track and manipulate epitenon cells (GLASTLin) through a combination of
genetic lineage tracing, single-cell RNA-sequencing, and depletion/inhibitions studies. This administrative
supplement builds on preliminary data gathered during completion of Aim 1 of the parent award wherein we
discovered that a GLASTLin epitenon cells are the sole expressors of the peptidase inhibitor 16 (Pi16) gene, a
key non-neuronal regulator of persistent pain. This suggests that Pi16 expression by epitenon cells may be a
therapeutic target to mitigate the pain associated with tendon injury. Therefore, in parallel with the parent award,
the proposed administrative supplement will test the central hypothesis that epitenon-derived cells are primary
drivers of the tendon pain response. In supplemental experiments to Aim 2A of the parent award, we will first
identify pain-related behavioral metrics that can be used to longitudinally evaluate tendon pain in mouse models.
We will then assess how loss of Pi16 via GLASTLin epitenon cell depletion affects the pain response during
healing by a combination of histological and pain-related behavioral analyses. Successful completion of these
experiments will identify epitenon cell-derived Pi16 as a potential target by which tendon-related pain can be
alleviated and establish methods to measure tendon pain in future studies.
项目概要
与肌腱损伤相关的疼痛是一个棘手的临床问题,显着影响患者的整体质量。
受影响患者的生活。目前治疗肌腱疼痛的方法是抗炎药(非甾体类抗炎药)
炎症药物(NSAIDS)和皮质类固醇)或阿片类药物;然而,抗炎药物可能会产生负面影响
影响肌腱愈合过程,长期使用阿片类药物可能导致依赖性并导致
全国阿片类药物公共卫生危机。因此,需要新的、更有针对性的机制来减轻疼痛
肌腱损伤率很高。家长奖旨在明确表腱细胞在肌腱愈合中发挥的总体作用
使用新型驱动程序 (GLASTCreERT) 通过以下组合来跟踪和操纵表腱细胞 (GLASTLin)
遗传谱系追踪、单细胞 RNA 测序和耗尽/抑制研究。本次行政
补充建立在完成家长奖目标 1 期间收集的初步数据的基础上,其中我们
发现 GLASTLin 表腱细胞是肽酶抑制剂 16 (Pi16) 基因的唯一表达者,
持续性疼痛的关键非神经元调节剂。这表明表膜细胞表达 Pi16 可能是
治疗目标是减轻与肌腱损伤相关的疼痛。因此,在发放家长奖的同时,
拟议的行政补充将检验表腱衍生细胞是主要细胞的中心假设
肌腱疼痛反应的驱动因素。在家长奖目标2A的补充实验中,我们首先
确定可用于纵向评估小鼠模型肌腱疼痛的疼痛相关行为指标。
然后,我们将评估 GLASTLin 表腱细胞耗竭导致 Pi16 的损失如何影响治疗过程中的疼痛反应。
通过组织学和疼痛相关行为分析的结合来治愈。顺利完成这些
实验将确定表腱细胞衍生的 Pi16 作为潜在靶标,通过该靶标可以治疗与肌腱相关的疼痛。
缓解并在未来的研究中建立测量肌腱疼痛的方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne E.C. Nichols其他文献
Anne E.C. Nichols的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne E.C. Nichols', 18)}}的其他基金
Epitenon-derived progenitor cells in tendon healing and adaptation
表腱衍生的祖细胞在肌腱愈合和适应中的作用
- 批准号:
10640168 - 财政年份:2022
- 资助金额:
$ 7.02万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 7.02万 - 项目类别: